Suchen
60 Degrees Pharmaceuticals Inc
SXTPWZur Watchlist hinzufügen
0.028USD
-0.002-6.35%
Trading geöffnet （ET）Kurse um 15 Minuten verzögert
0.00Marktkapitalisierung
--KGV TTM
mehr Informationen über 60 Degrees Pharmaceuticals Inc Unternehmen
60 Degrees Pharmaceuticals, Inc. is a specialty pharmaceutical company. The Company specializes in developing and marketing new medicines for the treatment and prevention of infectious diseases. It is focused on using biological science and applied research to develop and commercialize new therapies for the prevention and treatment of infectious diseases. The Company's pipeline under development covers development programs for vector-borne, fungal, and viral disease utilizing three of the Company’s products: new products that contain the ARAKODA regimen of Tafenoquine; new products that contain Tafenoquine, and Celgosivir. Its lead product, ARAKODA is an antimalarial indicated for the prophylaxis of malaria in patients aged 18 years of age and older. It is also conducting due diligence activities in relation to potential in-licensing of a product relevant to Lyme disease and an antimalarial combination partner for Tafenoquine for P. vivax malaria.
60 Degrees Pharmaceuticals Inc Informationen
BörsenkürzelSXTPW
Name des Unternehmens60 Degrees Pharmaceuticals Inc
IPO-datumJul 12, 2023
CEODr. Ll S. Dow, Ph.D.
Anzahl der mitarbeiter- -
WertpapierartCompany Warrant
Geschäftsjahresende- -
Addresse1025 Connecticut Avenue Nw
StadtWASHINGTON
BörseNASDAQ Capital Market Consolidated
LandUnited States of America
Postleitzahl20036
Telefon12023275422
Websitehttps://60degreespharma.com/
BörsenkürzelSXTPW
IPO-datumJul 12, 2023
CEODr. Ll S. Dow, Ph.D.
Führungskräfte von 60 Degrees Pharmaceuticals Inc
Name
Name/Position
Position
Aktienbesitz
Veränderung
Dr. Geoffrey S. Dow, Ph.D.
Dr. Geoffrey S. Dow, Ph.D.
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
--
--
Mr. Tyrone Miller
Mr. Tyrone Miller
Chief Financial Officer
Chief Financial Officer
--
--
Ms. Kristen Landon
Ms. Kristen Landon
Chief Commercial Officer
Chief Commercial Officer
--
--
Ms. Cheryl Xu
Ms. Cheryl Xu
Director
Director
--
--
Mr. Charles W. Allen
Mr. Charles W. Allen
Independent Director
Independent Director
--
--
Mr. Paul Field
Mr. Paul Field
Independent Director
Independent Director
--
--
Dr. Stephen Toovey
Dr. Stephen Toovey
Independent Director
Independent Director
--
--
Mr. Patrick Gaynes
Mr. Patrick Gaynes
Investor Relations Officer
Investor Relations Officer
--
--
Name
Name/Position
Position
Aktienbesitz
Veränderung
Dr. Geoffrey S. Dow, Ph.D.
Dr. Geoffrey S. Dow, Ph.D.
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
--
--
Mr. Tyrone Miller
Mr. Tyrone Miller
Chief Financial Officer
Chief Financial Officer
--
--
Ms. Kristen Landon
Ms. Kristen Landon
Chief Commercial Officer
Chief Commercial Officer
--
--
Ms. Cheryl Xu
Ms. Cheryl Xu
Director
Director
--
--
Mr. Charles W. Allen
Mr. Charles W. Allen
Independent Director
Independent Director
--
--
Mr. Paul Field
Mr. Paul Field
Independent Director
Independent Director
--
--
Häufig gestellte Fragen
Wer sind die fünf größten Anteilseigner von 60 Degrees Pharmaceuticals Inc?
Die fünf größten Anteilseigner von 60 Degrees Pharmaceuticals Inc sind: Dr. Geoffrey S. Dow, Ph.D.